Xwell (XWEL) EBT Growth (3y) (2013 - 2026)
Xwell (XWEL) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.90% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 13.42% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.67% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -7.07% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.73% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 70.10% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.19% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.13% |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | -23.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.62% |
| Dec 31, 2025 | 13.30% |
| Sep 30, 2025 | 69.92% |
| Jun 30, 2025 | 36.62% |
| Mar 31, 2025 | -18.43% |
| Dec 31, 2024 | -83.56% |
| Sep 30, 2024 | -39.32% |
| Jun 30, 2024 | 27.70% |
| Mar 31, 2024 | -42.96% |
| Dec 31, 2023 | 33.18% |
| Sep 30, 2023 | -20.41% |
| Jun 30, 2023 | 54.03% |
| Mar 31, 2023 | 18.39% |
| Dec 31, 2022 | -26.60% |
| Sep 30, 2022 | -17.13% |
| Jun 30, 2022 | -9.34% |
| Mar 31, 2022 | 0.84% |
| Dec 31, 2021 | 31.54% |
| Sep 30, 2021 | 60.50% |
| Jun 30, 2021 | -18.00% |